Validation of an Analytical HPLC Method for a New Diagnostic Octreotide Derivative for Neuroendocrine Tumors

Bibliografiske detaljer
Parent link:Pharmaceutical Chemistry Journal
Vol. 53, iss. 9.— 2019.— [P. 865-870]
Andre forfattere: Larkina M. S. Mariya Sergeevna, Krivoshchekov S. V. Sergey Vladimirovich, Podrezova E. V. Ekaterina Vladimirovna, Bragina O. D. Olga Dmitrievna, Chernov V. I. Vladimir Ivanovich, Nesterov E. A. Evgeny Alexandrovich, Bodenko V. V. Vitalina Vasiljevna, Belousov M. V. Mikhail Valerievich, Yusubov M. S. Mekhman Suleiman-Ogly (Suleimanovich)
Summary:Title screen
Preclinical studies of a new octreotide derivative with a chelate (DPAH-octreotide) that binds 99mTc for radiological diagnosis of neuroendocrine tumors are currently in progress. A method for preparing DPAH-octreotide is based on forming an amide bond between the amine of D-phenylalanine and the bifunctional chelate succinimid-1-yl 6-[bis(pyridin-2-ylmethyl)amino]hexanoate. An HPLC method for determining the identity, impurities, and quantitative content is proposed for DPAH-octreotide quality assurance. The validationprotocol established that the HPLC analytical method for determining DPAH-octreotide had quality parameters for specificity, detection limit, linearity, accuracy, precision, and intralaboratory precision that met requirements for analytical methods and could be used for quality control of the finished product during manufacturing of reagents for preparation of related radiopharmaceuticals.
Режим доступа: по договору с организацией-держателем ресурса
Udgivet: 2019
Fag:
Online adgang:https://doi.org/10.1007/s11094-019-02091-z
Format: Electronisk Book Chapter
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=662001

MARC

LEADER 00000naa0a2200000 4500
001 662001
005 20251204155318.0
035 |a (RuTPU)RU\TPU\network\33134 
035 |a RU\TPU\network\22977 
090 |a 662001 
100 |a 20200424d2019 k||y0rusy50 ba 
101 0 |a eng 
102 |a US 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Validation of an Analytical HPLC Method for a New Diagnostic Octreotide Derivative for Neuroendocrine Tumors  |f M. S. Larkina, S. V. Krivoshchekov, E. V. Podrezova [et al.] 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References: 10 tit.] 
330 |a Preclinical studies of a new octreotide derivative with a chelate (DPAH-octreotide) that binds 99mTc for radiological diagnosis of neuroendocrine tumors are currently in progress. A method for preparing DPAH-octreotide is based on forming an amide bond between the amine of D-phenylalanine and the bifunctional chelate succinimid-1-yl 6-[bis(pyridin-2-ylmethyl)amino]hexanoate. An HPLC method for determining the identity, impurities, and quantitative content is proposed for DPAH-octreotide quality assurance. The validationprotocol established that the HPLC analytical method for determining DPAH-octreotide had quality parameters for specificity, detection limit, linearity, accuracy, precision, and intralaboratory precision that met requirements for analytical methods and could be used for quality control of the finished product during manufacturing of reagents for preparation of related radiopharmaceuticals. 
333 |a Режим доступа: по договору с организацией-держателем ресурса 
461 |t Pharmaceutical Chemistry Journal 
463 |t Vol. 53, iss. 9  |v [P. 865-870]  |d 2019 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a octreotide derivative 
610 1 |a chelate 
610 1 |a technetium-99m 
610 1 |a HPLC 
610 1 |a validation 
610 1 |a хелаты 
610 1 |a технеций 
610 1 |a технеций-99м 
701 1 |a Larkina  |b M. S.  |g Mariya Sergeevna  |f 1984-  |c pharmacist  |c Professor; Senior Researcher of the Tomsk Polytechnic University, Doctor of Pharmaceutical Sciences  |3 (RuTPU)RU\TPU\pers\46781  |9 22417 
701 1 |a Krivoshchekov  |b S. V.  |c chemist  |c engineer of Tomsk Polytechnic University  |f 1987-  |g Sergey Vladimirovich  |3 (RuTPU)RU\TPU\pers\34574  |9 17936 
701 1 |a Podrezova  |b E. V.  |c Chemist  |c Engineer of Tomsk Polytechnic University  |f 1992-  |g Ekaterina Vladimirovna  |y Tomsk  |3 (RuTPU)RU\TPU\pers\40301  |9 21290 
701 1 |a Bragina  |b O. D.  |c specialist in the field of medical technology  |c Senior Researcher of the Tomsk Polytechnic University, Doctor of Medical Sciences  |f 1986-  |g Olga Dmitrievna  |y Tomsk  |3 (RuTPU)RU\TPU\pers\35943  |9 19084 
701 1 |a Chernov  |b V. I.  |c specialist in the field of medical technology  |c lead engineer of Tomsk Polytechnic University, doctor of medical sciences  |f 1962-  |g Vladimir Ivanovich  |3 (RuTPU)RU\TPU\pers\34191  |9 17725 
701 1 |a Nesterov  |b E. A.  |c Physicist, Specialist in the field of nuclear power engineering  |c Researcher of Tomsk Polytechnic University  |f 1976-  |g Evgeny Alexandrovich  |3 (RuTPU)RU\TPU\pers\32657  |9 16556 
701 1 |a Bodenko  |b V. V.  |c pharmacist  |c engineer at Tomsk Polytechnic University  |f 1997-  |g Vitalina Vasiljevna  |9 88553 
701 1 |a Belousov  |b M. V.  |c chemist  |c Professor of Tomsk Polytechnic University, Doctor of Pharmaceutical Sciences  |f 1963-  |g Mikhail Valerievich  |3 (RuTPU)RU\TPU\pers\45418  |9 21924 
701 1 |a Yusubov  |b M. S.  |c chemist  |c Professor of Tomsk Polytechnic University, Doctor of chemical sciences  |f 1961-  |g Mekhman Suleiman-Ogly (Suleimanovich)  |3 (RuTPU)RU\TPU\pers\31833  |9 15928 
801 2 |a RU  |b 63413507  |c 20210302  |g RCR 
850 |a 63413507 
856 4 |u https://doi.org/10.1007/s11094-019-02091-z  |z https://doi.org/10.1007/s11094-019-02091-z 
942 |c CF